Results 161 to 170 of about 126,252 (309)

Placebo in Functional Neurological Disorders: Promise and Controversy. [PDF]

Healthcare (Basel)
Szejko N, Abusrair A, Pasierski T, Schmitt S, Cramer C, Pietrzykowski T, Dunalska A, Saramak K, Śmiłowska K, Serranova T, Müller-Vahl KR.   +10 more
europepmc   +1 more source

The Effectiveness of Acceptance and Commitment Therapy Group Intervention (Navigator ACT) for Parents of Children With Neurodevelopmental Disabilities: A Randomized Controlled Trial

Autism Research, EarlyView.
ABSTRACT High levels of parental stress and psychological inflexibility are common among caregivers raising children with neurodevelopmental disabilities. Navigator ACT is a group‐based treatment developed to increase psychological flexibility and reduce the impact of stress among parents of children with various disabilities (e.g., autism spectrum ...
T. Holmberg Bergman, P. Lappalainen, A. Ghaderi, T. Hirvikoski   +3 more
wiley   +1 more source

458 Randomized, Double-Blinded, Placebo Controlled Multi-Center Trial of Etanercept in the Treatment of Alcoholic Hepatitis

, 2008
Nicholas C. Boetticher, Craig J. Peine, Paul Y. Kwo, Gary A. Abrams, Tushar Patel, Bashar Aqel, Gregory J. Gores, Craig J. McClain, Patrick S. Kamath, William S. Harmsen, Vijay H. Shah   +10 more
openalex   +1 more source

The effect of open-label placebo on anxiety, cortisol, and pain levels in children with procedural pain. [PDF]

Front Pediatr
Friedel AL, Szallies T, Oberlohmann J, Peters L, Benson S, Schedlowski M, Tschiedel E.   +6 more
europepmc   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Placebo controlled trials in neuromyelitis optica are needed and ethical [PDF]

, 2015
Bruce Cree
openalex   +1 more source

Magnitude of the Digital Placebo Effect and Its Moderators on Generalized Anxiety Symptoms: Systematic Review and Meta-Analysis. [PDF]

J Med Internet Res
Hosono T, Tsutsumi R, Niwa Y, Kondoh M.
europepmc   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

The D2-D3 Study: a randomised, double-blind, placebo-controlled food-fortification trial in women, comparing the efficacy of 15ug/d vitamin D2 vs vitamin D3 in raising serum 25OHD levels [PDF]

, 2015
Laura Tripkovic, L. Wilson, Kathryn Hart, Ruan Elliott, Colin P. Smith, Giselda Bucca, Simon Penson, Gemma A. Chope, Elina Hyppönen, Jacqueline Berry, S. A. Lanham‐New   +10 more
openalex   +1 more source

Talking placebo: a qualitative study of patients' attitudes toward open-label placebo implementation into clinical practice. [PDF]

Front Psychol
Frey Nascimento A, Bakis B, Gaab J, Schneider T, Papadopoulou A, Ritter M, Bernstein MH, Blease CR, Locher C.   +8 more
europepmc   +1 more source